Clinical Trials

An HBV gene editing clinical trial has been approved in Moldova, but the challenges go beyond science and industry.

PicnicHealth Co-founder and CEO Noga Leviner foresees AI as the augur of greater observational research

Technological advances are opening up new drug development opportunities for rare diseases.

Digital twins in clinical trials are changing how research is performed – but it won’t be a revolution, according to Phesi CEO Gen Li.

Research suggests diabetes patients using SGLT-2 and DPP-4 inhibitors have a decreased risk of developing dementia.

How technology is enabling new access to clinical trials for those without the means to participate in traditional methods

If used correctly, AI and ML expand our knowledge of biology and vastly improve the speed of success in the clinic.

Discussing the finer points of AI as a catalyst for pharmaceutical innovation

How does prescreening improve clinical trials? Cara Brant, CEO of Clinical Trial Media, explains.

Older adults are underrepresented in clinical trials. This needs to change.